社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Leaynx
IP属地：未知
+关注
帖子 · 27
帖子 · 27
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Leaynx
Leaynx
·
2021-12-23
Thanks for sharing
非常抱歉，此主贴已删除
看
2,199
回复
评论
点赞
4
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-12-07
Go for apple
4 of the Safest Dividend Stocks That'll Help You Crush Inflation<blockquote>4只最安全的股息股票将帮助您抑制通货膨胀</blockquote>
Apple and four other tech stalwarts are well insulated from inflation.
4 of the Safest Dividend Stocks That'll Help You Crush Inflation<blockquote>4只最安全的股息股票将帮助您抑制通货膨胀</blockquote>
看
2,241
回复
评论
点赞
2
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-21
ASML[财迷]
非常抱歉，此主贴已删除
看
1,967
回复
3
点赞
5
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-18
Wow
Starbucks, Amazon team up to open cashier-less store, cafe in NYC<blockquote>星巴克和亚马逊联手在纽约开设无收银员商店和咖啡馆</blockquote>
Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in
Starbucks, Amazon team up to open cashier-less store, cafe in NYC<blockquote>星巴克和亚马逊联手在纽约开设无收银员商店和咖啡馆</blockquote>
看
2,701
回复
评论
点赞
5
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-13
[强]
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>
Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>
看
2,011
回复
评论
点赞
5
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-13
Noted with thanks
非常抱歉，此主贴已删除
看
2,683
回复
1
点赞
7
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-10-19
NIO good
非常抱歉，此主贴已删除
看
2,100
回复
1
点赞
8
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-09-30
Nice Starbucks
非常抱歉，此主贴已删除
看
4,431
回复
2
点赞
8
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-09-23
Good
非常抱歉，此主贴已删除
看
1,935
回复
1
点赞
6
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-09-21
Like
Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?<blockquote>Greenidge Generation Holdings(GREE)、Support.com(SPRT)股票新闻和预测：格力为何下跌？</blockquote>
GREE shares continue to collapse after the merger deal with Support.com (SPRT). GREE stock falls ove
Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?<blockquote>Greenidge Generation Holdings(GREE)、Support.com(SPRT)股票新闻和预测：格力为何下跌？</blockquote>
看
1,789
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3587034259149930","uuid":"3587034259149930","gmtCreate":1623940234980,"gmtModify":1623941703944,"name":"Leaynx","pinyin":"leaynx","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":18,"headSize":448,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.07.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698031802,"gmtCreate":1640257493340,"gmtModify":1640257493571,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Thanks for sharing","listText":"Thanks for sharing","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698031802","repostId":"2193422197","repostType":4,"isVote":1,"tweetType":1,"viewCount":2199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606640777,"gmtCreate":1638877145202,"gmtModify":1638877145385,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Go for apple","listText":"Go for apple","text":"Go for apple","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606640777","repostId":"1153880755","repostType":4,"repost":{"id":"1153880755","kind":"news","pubTimestamp":1638867395,"share":"https://www.laohu8.com/m/news/1153880755?lang=zh_CN&edition=full","pubTime":"2021-12-07 16:56","market":"us","language":"en","title":"4 of the Safest Dividend Stocks That'll Help You Crush Inflation<blockquote>4只最安全的股息股票将帮助您抑制通货膨胀</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1153880755","media":"Motley Fool","summary":"Apple and four other tech stalwarts are well insulated from inflation.","content":"<p>Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears of an economic slowdown and causing investors to rotate from dividend stocks toward lower-risk bonds.</p><p><blockquote>由于投资者担心成本上升和未来估值下降，通胀上升正在对许多高增长股票造成严重破坏。对抗通胀的利率上升也引发了人们对经济放缓的担忧，并导致投资者从股息股票转向风险较低的债券。</blockquote></p><p> Faced with these challenges, it might seem like a bad idea to buy dividend-paying tech stocks. However, these four tech dividend stocks should remain resilient and easily withstand the upcoming inflation-related challenges.</p><p><blockquote>面对这些挑战，购买派息科技股似乎是个坏主意。然而，这四只科技股息股应该保持弹性，并轻松抵御即将到来的通胀相关挑战。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3710057a11169b9e18f5bf46888ca7fb\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Apple.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：苹果。</span></p></blockquote></p><p> <b>1. Apple</b></p><p><blockquote><b>1.苹果</b></blockquote></p><p> <b>Apple</b> only pays a forward dividend yield of 0.5%, but its lowpayout ratioof 15% indicates there's still plenty of room for much higher payments. Apple's stock price has risen nearly 270% over the past three years, but it still doesn't look terribly expensive at 29 times forward earnings.</p><p><blockquote><b>苹果</b>仅支付0.5%的远期股息收益率，但其15%的低派息率表明仍有很大的空间来支付更高的股息。苹果的股价在过去三年里上涨了近270%，但29倍的预期市盈率看起来仍然不是很贵。</blockquote></p><p> Apple is an inflation-resistant company for two simple reasons. First, it has the clout to negotiate more favorable prices from its suppliers. Second, it probably won't lose a lot of its loyal customers if it charges higher prices for its hardware since they're already firmly locked into its software ecosystem.</p><p><blockquote>苹果是一家抗通胀公司，原因很简单，有两个。首先，它有能力从供应商那里谈判更优惠的价格。其次，如果它对硬件收取更高的价格，它可能不会失去很多忠实客户，因为他们已经牢牢地锁定在其软件生态系统中。</blockquote></p><p> Apple has also consistently executed big stock buybacks, which have reduced its outstanding shares by nearly 22% over the past five years. Spending more cash on those buybacks, which boosts the value of its remaining shares, is a better strategy than letting its cash stagnate in an inflationary environment.</p><p><blockquote>苹果还持续执行大规模股票回购，过去五年使其流通股减少了近22%。在这些回购上花费更多现金，从而提高其剩余股票的价值，是比让现金在通胀环境中停滞不前更好的策略。</blockquote></p><p> Apple will face a near-term slowdown as it grapples with supply chain constraints, but its long-term outlook is still bright. Its services ecosystem continues to expand, and it will eventually expand into new next-gen markets like augmented reality, virtual reality, and connected cars.</p><p><blockquote>由于努力应对供应链限制，苹果将面临近期经济放缓，但其长期前景仍然光明。其服务生态系统不断扩展，最终将扩展到增强现实、虚拟现实和联网汽车等新的下一代市场。</blockquote></p><p> <b>2. Verizon</b></p><p><blockquote><b>2.威瑞森</b></blockquote></p><p> <b>Verizon</b> pays a forward dividend yield of 5%. The telecom giant has raised that dividend annually for 15 straight years, and it's spent less than half of its earnings per share on those payments over the past 12 months. The stock also trades at just nine times forward earnings.</p><p><blockquote><b>Verizon</b>支付5%的远期股息率。这家电信巨头已连续15年每年提高股息，在过去12个月里，它在这些支付上的支出不到每股收益的一半。该股的预期市盈率也仅为九倍。</blockquote></p><p> At first glance, Verizon seems like a lackluster investment. It's declined more than 10% over the past three years as the <b>S&P 500</b> has risen nearly 70%.</p><p><blockquote>乍一看，Verizon似乎是一项乏善可陈的投资。过去三年下降了10%以上<b>标普500</b>已上涨近70%。</blockquote></p><p> However, Verizon's stock will likely remain stable as rising inflation and higher interest rates rattle the markets. As the largest wireless carrier in the U.S., Verizon can likely pass on most of its higher costs onto consumers without significantly increasing its churn rates. It's also a more streamlined company than <b>AT&T</b>, which is still trying toundo the damageof the debt-fueled expansions of its media and pay-TV ecosystems.</p><p><blockquote>然而，随着通胀上升和利率上升扰乱市场，Verizon的股价可能会保持稳定。作为美国最大的无线运营商，Verizon可能会将大部分较高的成本转嫁给消费者，而不会显着增加其流失率。它也是一家比<b>AT&T</b>该公司仍在努力弥补债务推动的媒体和付费电视生态系统扩张造成的损害。</blockquote></p><p> Verizon's stable returns, sticky ecosystem, high dividend, and low valuation will all make it an ideal safe-haven stock in an inflationary market.</p><p><blockquote>Verizon稳定的回报、粘性生态系统、高股息和低估值都将使其成为通胀市场中理想的避险股票。</blockquote></p><p> <b>3. Qualcomm</b></p><p><blockquote><b>3.高通</b></blockquote></p><p> <b>Qualcomm</b>, one of the world's largest mobile chipmakers, pays a forward dividend yield of 1.5%. It's raised its annual payout over the past two years, and it's only spent about a third of its earnings on its dividends over the past 12 months.</p><p><blockquote><b>Qualcomm</b>是全球最大的移动芯片制造商之一，支付1.5%的远期股息率。过去两年，该公司提高了年度派息，而过去12个月，该公司仅将收益的三分之一左右用于股息。</blockquote></p><p> Qualcomm's two main businesses are both well-insulated from inflation. Its Snapdragon system on chips (SoCs), which bundle together a mobile CPU, GPU, and baseband modem, power most of the world's high-end smartphones. They can also be found in virtual reality headsets, cars, and drones. The secular growth of those markets will give Qualcomm plenty of pricing power.</p><p><blockquote>高通的两项主要业务都很好地抵御了通货膨胀。其骁龙片上系统（SoC）将移动CPU、GPU和基带调制解调器捆绑在一起，为世界上大多数高端智能手机提供动力。它们也可以在虚拟现实耳机、汽车和无人机中找到。这些市场的长期增长将赋予高通充足的定价权。</blockquote></p><p> Its licensing business, which leverages its portfolio of wireless patents to earn a cut of every smartphone sold worldwide, also generates a stable stream of high-margin revenue. It then plows a large portion of that excess cash into big buybacks and dividends.</p><p><blockquote>其授权业务利用其无线专利组合从全球销售的每部智能手机中赚取分成，也产生了稳定的高利润收入流。然后，它将大部分多余现金投入到大规模回购和股息中。</blockquote></p><p> Qualcomm's stock has already risen more than 200% as investors have recognized those long-term strengths, but it still looks cheap at 17 times forward earnings.</p><p><blockquote>随着投资者认识到这些长期优势，高通的股价已经上涨了200%以上，但预计市盈率为17倍，看起来仍然很便宜。</blockquote></p><p> <b>4. Texas Instruments</b></p><p><blockquote><b>4.德州仪器</b></blockquote></p><p> <b>Texas Instruments</b> manufactures a wide range of analog and embedded chips for consumer electronics, cars, industrial machines, and other markets. These chips aren't as powerful as Qualcomm's mobile chips, but they're just as essential and less capital-intensive to produce.</p><p><blockquote><b>德州仪器</b>为消费电子、汽车、工业机器和其他市场制造各种模拟和嵌入式芯片。这些芯片不如高通的移动芯片强大，但它们同样重要，生产资本密集度更低。</blockquote></p><p> Unlike Qualcomm, which outsources the production of its chips to third-party foundries, TI manufactures its own chips in-house. That business model insulates it from the ongoing chip shortage, and its cost-cutting migration from 200mm to 300mm wafers over the past few years enabled it to significantly reduce its own manufacturing costs and boost its gross margins.</p><p><blockquote>与将芯片生产外包给第三方代工厂的高通不同，TI在内部制造自己的芯片。这种商业模式使其免受持续芯片短缺的影响，过去几年其从200毫米晶圆到300毫米晶圆的成本削减迁移使其能够显着降低自身制造成本并提高毛利率。</blockquote></p><p></p><p> TI's business is naturally resistant to inflation since it has much better control over its own supply chain and operating expenses than other chipmakers, and it generates plenty of excess cash for buybacks and dividends. It reduced its number of outstanding shares by 46% between 2004 and 2020, and it's raised its dividend annually for 18 straight years. It currently pays a forward dividend yield of 2.4%, which is supported by a sustainable payout ratio of 52%.</p><p><blockquote>TI的业务自然能够抵抗通货膨胀，因为它比其他芯片制造商更好地控制自己的供应链和运营费用，并且它产生大量多余现金用于回购和股息。2004年至2020年间，该公司已发行股票数量减少了46%，并连续18年每年提高股息。它目前支付2.4%的远期股息收益率，并得到52%的可持续派息率的支持。</blockquote></p><p> TI's stock has more than doubled over the past three years, but it still trades at 23 times forward earnings. That reasonable valuation, along with its healthy yield and stable business, makes TI a reliable and inflation-resistant tech stock.</p><p><blockquote>TI的股价在过去三年中上涨了一倍多，但其预期市盈率仍为23倍。合理的估值，加上其健康的收益率和稳定的业务，使TI成为一只可靠且抗通胀的科技股。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 of the Safest Dividend Stocks That'll Help You Crush Inflation<blockquote>4只最安全的股息股票将帮助您抑制通货膨胀</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 of the Safest Dividend Stocks That'll Help You Crush Inflation<blockquote>4只最安全的股息股票将帮助您抑制通货膨胀</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-07 16:56</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears of an economic slowdown and causing investors to rotate from dividend stocks toward lower-risk bonds.</p><p><blockquote>由于投资者担心成本上升和未来估值下降，通胀上升正在对许多高增长股票造成严重破坏。对抗通胀的利率上升也引发了人们对经济放缓的担忧，并导致投资者从股息股票转向风险较低的债券。</blockquote></p><p> Faced with these challenges, it might seem like a bad idea to buy dividend-paying tech stocks. However, these four tech dividend stocks should remain resilient and easily withstand the upcoming inflation-related challenges.</p><p><blockquote>面对这些挑战，购买派息科技股似乎是个坏主意。然而，这四只科技股息股应该保持弹性，并轻松抵御即将到来的通胀相关挑战。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3710057a11169b9e18f5bf46888ca7fb\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Apple.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：苹果。</span></p></blockquote></p><p> <b>1. Apple</b></p><p><blockquote><b>1.苹果</b></blockquote></p><p> <b>Apple</b> only pays a forward dividend yield of 0.5%, but its lowpayout ratioof 15% indicates there's still plenty of room for much higher payments. Apple's stock price has risen nearly 270% over the past three years, but it still doesn't look terribly expensive at 29 times forward earnings.</p><p><blockquote><b>苹果</b>仅支付0.5%的远期股息收益率，但其15%的低派息率表明仍有很大的空间来支付更高的股息。苹果的股价在过去三年里上涨了近270%，但29倍的预期市盈率看起来仍然不是很贵。</blockquote></p><p> Apple is an inflation-resistant company for two simple reasons. First, it has the clout to negotiate more favorable prices from its suppliers. Second, it probably won't lose a lot of its loyal customers if it charges higher prices for its hardware since they're already firmly locked into its software ecosystem.</p><p><blockquote>苹果是一家抗通胀公司，原因很简单，有两个。首先，它有能力从供应商那里谈判更优惠的价格。其次，如果它对硬件收取更高的价格，它可能不会失去很多忠实客户，因为他们已经牢牢地锁定在其软件生态系统中。</blockquote></p><p> Apple has also consistently executed big stock buybacks, which have reduced its outstanding shares by nearly 22% over the past five years. Spending more cash on those buybacks, which boosts the value of its remaining shares, is a better strategy than letting its cash stagnate in an inflationary environment.</p><p><blockquote>苹果还持续执行大规模股票回购，过去五年使其流通股减少了近22%。在这些回购上花费更多现金，从而提高其剩余股票的价值，是比让现金在通胀环境中停滞不前更好的策略。</blockquote></p><p> Apple will face a near-term slowdown as it grapples with supply chain constraints, but its long-term outlook is still bright. Its services ecosystem continues to expand, and it will eventually expand into new next-gen markets like augmented reality, virtual reality, and connected cars.</p><p><blockquote>由于努力应对供应链限制，苹果将面临近期经济放缓，但其长期前景仍然光明。其服务生态系统不断扩展，最终将扩展到增强现实、虚拟现实和联网汽车等新的下一代市场。</blockquote></p><p> <b>2. Verizon</b></p><p><blockquote><b>2.威瑞森</b></blockquote></p><p> <b>Verizon</b> pays a forward dividend yield of 5%. The telecom giant has raised that dividend annually for 15 straight years, and it's spent less than half of its earnings per share on those payments over the past 12 months. The stock also trades at just nine times forward earnings.</p><p><blockquote><b>Verizon</b>支付5%的远期股息率。这家电信巨头已连续15年每年提高股息，在过去12个月里，它在这些支付上的支出不到每股收益的一半。该股的预期市盈率也仅为九倍。</blockquote></p><p> At first glance, Verizon seems like a lackluster investment. It's declined more than 10% over the past three years as the <b>S&P 500</b> has risen nearly 70%.</p><p><blockquote>乍一看，Verizon似乎是一项乏善可陈的投资。过去三年下降了10%以上<b>标普500</b>已上涨近70%。</blockquote></p><p> However, Verizon's stock will likely remain stable as rising inflation and higher interest rates rattle the markets. As the largest wireless carrier in the U.S., Verizon can likely pass on most of its higher costs onto consumers without significantly increasing its churn rates. It's also a more streamlined company than <b>AT&T</b>, which is still trying toundo the damageof the debt-fueled expansions of its media and pay-TV ecosystems.</p><p><blockquote>然而，随着通胀上升和利率上升扰乱市场，Verizon的股价可能会保持稳定。作为美国最大的无线运营商，Verizon可能会将大部分较高的成本转嫁给消费者，而不会显着增加其流失率。它也是一家比<b>AT&T</b>该公司仍在努力弥补债务推动的媒体和付费电视生态系统扩张造成的损害。</blockquote></p><p> Verizon's stable returns, sticky ecosystem, high dividend, and low valuation will all make it an ideal safe-haven stock in an inflationary market.</p><p><blockquote>Verizon稳定的回报、粘性生态系统、高股息和低估值都将使其成为通胀市场中理想的避险股票。</blockquote></p><p> <b>3. Qualcomm</b></p><p><blockquote><b>3.高通</b></blockquote></p><p> <b>Qualcomm</b>, one of the world's largest mobile chipmakers, pays a forward dividend yield of 1.5%. It's raised its annual payout over the past two years, and it's only spent about a third of its earnings on its dividends over the past 12 months.</p><p><blockquote><b>Qualcomm</b>是全球最大的移动芯片制造商之一，支付1.5%的远期股息率。过去两年，该公司提高了年度派息，而过去12个月，该公司仅将收益的三分之一左右用于股息。</blockquote></p><p> Qualcomm's two main businesses are both well-insulated from inflation. Its Snapdragon system on chips (SoCs), which bundle together a mobile CPU, GPU, and baseband modem, power most of the world's high-end smartphones. They can also be found in virtual reality headsets, cars, and drones. The secular growth of those markets will give Qualcomm plenty of pricing power.</p><p><blockquote>高通的两项主要业务都很好地抵御了通货膨胀。其骁龙片上系统（SoC）将移动CPU、GPU和基带调制解调器捆绑在一起，为世界上大多数高端智能手机提供动力。它们也可以在虚拟现实耳机、汽车和无人机中找到。这些市场的长期增长将赋予高通充足的定价权。</blockquote></p><p> Its licensing business, which leverages its portfolio of wireless patents to earn a cut of every smartphone sold worldwide, also generates a stable stream of high-margin revenue. It then plows a large portion of that excess cash into big buybacks and dividends.</p><p><blockquote>其授权业务利用其无线专利组合从全球销售的每部智能手机中赚取分成，也产生了稳定的高利润收入流。然后，它将大部分多余现金投入到大规模回购和股息中。</blockquote></p><p> Qualcomm's stock has already risen more than 200% as investors have recognized those long-term strengths, but it still looks cheap at 17 times forward earnings.</p><p><blockquote>随着投资者认识到这些长期优势，高通的股价已经上涨了200%以上，但预计市盈率为17倍，看起来仍然很便宜。</blockquote></p><p> <b>4. Texas Instruments</b></p><p><blockquote><b>4.德州仪器</b></blockquote></p><p> <b>Texas Instruments</b> manufactures a wide range of analog and embedded chips for consumer electronics, cars, industrial machines, and other markets. These chips aren't as powerful as Qualcomm's mobile chips, but they're just as essential and less capital-intensive to produce.</p><p><blockquote><b>德州仪器</b>为消费电子、汽车、工业机器和其他市场制造各种模拟和嵌入式芯片。这些芯片不如高通的移动芯片强大，但它们同样重要，生产资本密集度更低。</blockquote></p><p> Unlike Qualcomm, which outsources the production of its chips to third-party foundries, TI manufactures its own chips in-house. That business model insulates it from the ongoing chip shortage, and its cost-cutting migration from 200mm to 300mm wafers over the past few years enabled it to significantly reduce its own manufacturing costs and boost its gross margins.</p><p><blockquote>与将芯片生产外包给第三方代工厂的高通不同，TI在内部制造自己的芯片。这种商业模式使其免受持续芯片短缺的影响，过去几年其从200毫米晶圆到300毫米晶圆的成本削减迁移使其能够显着降低自身制造成本并提高毛利率。</blockquote></p><p></p><p> TI's business is naturally resistant to inflation since it has much better control over its own supply chain and operating expenses than other chipmakers, and it generates plenty of excess cash for buybacks and dividends. It reduced its number of outstanding shares by 46% between 2004 and 2020, and it's raised its dividend annually for 18 straight years. It currently pays a forward dividend yield of 2.4%, which is supported by a sustainable payout ratio of 52%.</p><p><blockquote>TI的业务自然能够抵抗通货膨胀，因为它比其他芯片制造商更好地控制自己的供应链和运营费用，并且它产生大量多余现金用于回购和股息。2004年至2020年间，该公司已发行股票数量减少了46%，并连续18年每年提高股息。它目前支付2.4%的远期股息收益率，并得到52%的可持续派息率的支持。</blockquote></p><p> TI's stock has more than doubled over the past three years, but it still trades at 23 times forward earnings. That reasonable valuation, along with its healthy yield and stable business, makes TI a reliable and inflation-resistant tech stock.</p><p><blockquote>TI的股价在过去三年中上涨了一倍多，但其预期市盈率仍为23倍。合理的估值，加上其健康的收益率和稳定的业务，使TI成为一只可靠且抗通胀的科技股。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/06/safe-dividend-stocks-that-help-crush-inflation/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QCOM":"高通","AAPL":"苹果","VZ":"Verizon Comms","TXN":"德州仪器"},"source_url":"https://www.fool.com/investing/2021/12/06/safe-dividend-stocks-that-help-crush-inflation/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153880755","content_text":"Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears of an economic slowdown and causing investors to rotate from dividend stocks toward lower-risk bonds.\nFaced with these challenges, it might seem like a bad idea to buy dividend-paying tech stocks. However, these four tech dividend stocks should remain resilient and easily withstand the upcoming inflation-related challenges.\nImage source: Apple.\n1. Apple\nApple only pays a forward dividend yield of 0.5%, but its lowpayout ratioof 15% indicates there's still plenty of room for much higher payments. Apple's stock price has risen nearly 270% over the past three years, but it still doesn't look terribly expensive at 29 times forward earnings.\nApple is an inflation-resistant company for two simple reasons. First, it has the clout to negotiate more favorable prices from its suppliers. Second, it probably won't lose a lot of its loyal customers if it charges higher prices for its hardware since they're already firmly locked into its software ecosystem.\nApple has also consistently executed big stock buybacks, which have reduced its outstanding shares by nearly 22% over the past five years. Spending more cash on those buybacks, which boosts the value of its remaining shares, is a better strategy than letting its cash stagnate in an inflationary environment.\nApple will face a near-term slowdown as it grapples with supply chain constraints, but its long-term outlook is still bright. Its services ecosystem continues to expand, and it will eventually expand into new next-gen markets like augmented reality, virtual reality, and connected cars.\n2. Verizon\nVerizon pays a forward dividend yield of 5%. The telecom giant has raised that dividend annually for 15 straight years, and it's spent less than half of its earnings per share on those payments over the past 12 months. The stock also trades at just nine times forward earnings.\nAt first glance, Verizon seems like a lackluster investment. It's declined more than 10% over the past three years as the S&P 500 has risen nearly 70%.\nHowever, Verizon's stock will likely remain stable as rising inflation and higher interest rates rattle the markets. As the largest wireless carrier in the U.S., Verizon can likely pass on most of its higher costs onto consumers without significantly increasing its churn rates. It's also a more streamlined company than AT&T, which is still trying toundo the damageof the debt-fueled expansions of its media and pay-TV ecosystems.\nVerizon's stable returns, sticky ecosystem, high dividend, and low valuation will all make it an ideal safe-haven stock in an inflationary market.\n3. Qualcomm\nQualcomm, one of the world's largest mobile chipmakers, pays a forward dividend yield of 1.5%. It's raised its annual payout over the past two years, and it's only spent about a third of its earnings on its dividends over the past 12 months.\nQualcomm's two main businesses are both well-insulated from inflation. Its Snapdragon system on chips (SoCs), which bundle together a mobile CPU, GPU, and baseband modem, power most of the world's high-end smartphones. They can also be found in virtual reality headsets, cars, and drones. The secular growth of those markets will give Qualcomm plenty of pricing power.\nIts licensing business, which leverages its portfolio of wireless patents to earn a cut of every smartphone sold worldwide, also generates a stable stream of high-margin revenue. It then plows a large portion of that excess cash into big buybacks and dividends.\nQualcomm's stock has already risen more than 200% as investors have recognized those long-term strengths, but it still looks cheap at 17 times forward earnings.\n4. Texas Instruments\nTexas Instruments manufactures a wide range of analog and embedded chips for consumer electronics, cars, industrial machines, and other markets. These chips aren't as powerful as Qualcomm's mobile chips, but they're just as essential and less capital-intensive to produce.\nUnlike Qualcomm, which outsources the production of its chips to third-party foundries, TI manufactures its own chips in-house. That business model insulates it from the ongoing chip shortage, and its cost-cutting migration from 200mm to 300mm wafers over the past few years enabled it to significantly reduce its own manufacturing costs and boost its gross margins.\nTI's business is naturally resistant to inflation since it has much better control over its own supply chain and operating expenses than other chipmakers, and it generates plenty of excess cash for buybacks and dividends. It reduced its number of outstanding shares by 46% between 2004 and 2020, and it's raised its dividend annually for 18 straight years. It currently pays a forward dividend yield of 2.4%, which is supported by a sustainable payout ratio of 52%.\nTI's stock has more than doubled over the past three years, but it still trades at 23 times forward earnings. That reasonable valuation, along with its healthy yield and stable business, makes TI a reliable and inflation-resistant tech stock.","news_type":1,"symbols_score_info":{"TXN":0.9,"AAPL":0.9,"QCOM":0.9,"VZ":0.9}},"isVote":1,"tweetType":1,"viewCount":2241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872868915,"gmtCreate":1637477026700,"gmtModify":1637477026843,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"ASML[财迷] ","listText":"ASML[财迷] ","text":"ASML[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/872868915","repostId":"2184782893","repostType":4,"isVote":1,"tweetType":1,"viewCount":1967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878786455,"gmtCreate":1637233520376,"gmtModify":1637233520462,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878786455","repostId":"1171955198","repostType":4,"repost":{"id":"1171955198","kind":"news","pubTimestamp":1637233373,"share":"https://www.laohu8.com/m/news/1171955198?lang=zh_CN&edition=full","pubTime":"2021-11-18 19:02","market":"us","language":"en","title":"Starbucks, Amazon team up to open cashier-less store, cafe in NYC<blockquote>星巴克和亚马逊联手在纽约开设无收银员商店和咖啡馆</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1171955198","media":"Yahoo","summary":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in ","content":"<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.</p><p><blockquote>星巴克(SBUX)与亚马逊(AMZN)Go合作，向纽约市的消费者提供一种新的商店概念——没有任何收银员。</blockquote></p><p> The new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.</p><p><blockquote>新的星巴克皮卡位于公园和列克星敦大道之间的第59街，将于11月18日周四向公众开放。两家公司周四宣布，零售体验使用星巴克应用程序上的提前订购功能和Amazon Go的Just Walk Out技术来创建无接触体验。</blockquote></p><p> The team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.</p><p><blockquote>该团队是正在进行的新冠肺炎时代趋势的一部分，即利用有利于人类接触的技术来加快请求，并减少传播的机会。</blockquote></p><p> The two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.</p><p><blockquote>亚马逊实体零售和技术副总裁迪利普·库马尔（Dilip Kumar）在一份声明中表示，这两家巨头正在联手创造“一个共同的愿景，即提供以客户为中心的创新店内体验”。</blockquote></p><p> Dubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.</p><p><blockquote>该系统被称为星巴克Pickup with Amazon Go，让顾客能够选择他们的体验，“无论是利用星巴克和亚马逊应用程序在旅途中购买食品和饮料，还是决定留在休息室享受传统的第三名体验星巴克以其闻名，”星巴克高管凯蒂·杨(Katie Young)说。</blockquote></p><p> In order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.</p><p><blockquote>为了进入Amazon GO市场和商店的休息区，他们必须扫描亚马逊购物应用程序、Amazon One或信用卡中的“店内代码”。一旦消费者进入该位置，他们可以像任何其他亚马逊Go位置一样在市场购物，拿起他们的星巴克移动订单离开——或者选择停留一段时间。</blockquote></p><p> When guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.</p><p><blockquote>当客人从货架上取下任何商品时，它将立即被添加到他们的虚拟购物车中，如果顾客放回商品，它将从购物车中出来。根据新闻稿，一旦顾客离开商店的Amazon Go market部分，他们的卡将被扣款，收据预计将在几个小时内收到，如果不是更快的话。</blockquote></p><p> Items that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.</p><p><blockquote>除了在其他Amazon Go地点可以找到的商品外，还可以提货的商品包括经典的星巴克食品，如真空蛋咬、早餐三明治和蛋白质盒。其中包括厨房火鸡和切达三明治，以及布法罗风格的包装。</blockquote></p><p> In addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.</p><p><blockquote>除此之外，货架上还将摆满当地知名的美食，包括源氏寿司、约克街、木兰面包店、Ess-a-bagel等。</blockquote></p><p> As Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.</p><p><blockquote>随着星巴克一头扎进数字化领域，其忠诚度计划使用量飙升，两家公司计划在未来一年内总共开设至少三家星巴克Pickup Amazon Go商店，第二家商店将在位于第40街和第8大道的纽约时报大楼开业。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks, Amazon team up to open cashier-less store, cafe in NYC<blockquote>星巴克和亚马逊联手在纽约开设无收银员商店和咖啡馆</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks, Amazon team up to open cashier-less store, cafe in NYC<blockquote>星巴克和亚马逊联手在纽约开设无收银员商店和咖啡馆</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo</strong><span class=\"h-time small\">2021-11-18 19:02</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.</p><p><blockquote>星巴克(SBUX)与亚马逊(AMZN)Go合作，向纽约市的消费者提供一种新的商店概念——没有任何收银员。</blockquote></p><p> The new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.</p><p><blockquote>新的星巴克皮卡位于公园和列克星敦大道之间的第59街，将于11月18日周四向公众开放。两家公司周四宣布，零售体验使用星巴克应用程序上的提前订购功能和Amazon Go的Just Walk Out技术来创建无接触体验。</blockquote></p><p> The team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.</p><p><blockquote>该团队是正在进行的新冠肺炎时代趋势的一部分，即利用有利于人类接触的技术来加快请求，并减少传播的机会。</blockquote></p><p> The two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.</p><p><blockquote>亚马逊实体零售和技术副总裁迪利普·库马尔（Dilip Kumar）在一份声明中表示，这两家巨头正在联手创造“一个共同的愿景，即提供以客户为中心的创新店内体验”。</blockquote></p><p> Dubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.</p><p><blockquote>该系统被称为星巴克Pickup with Amazon Go，让顾客能够选择他们的体验，“无论是利用星巴克和亚马逊应用程序在旅途中购买食品和饮料，还是决定留在休息室享受传统的第三名体验星巴克以其闻名，”星巴克高管凯蒂·杨(Katie Young)说。</blockquote></p><p> In order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.</p><p><blockquote>为了进入Amazon GO市场和商店的休息区，他们必须扫描亚马逊购物应用程序、Amazon One或信用卡中的“店内代码”。一旦消费者进入该位置，他们可以像任何其他亚马逊Go位置一样在市场购物，拿起他们的星巴克移动订单离开——或者选择停留一段时间。</blockquote></p><p> When guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.</p><p><blockquote>当客人从货架上取下任何商品时，它将立即被添加到他们的虚拟购物车中，如果顾客放回商品，它将从购物车中出来。根据新闻稿，一旦顾客离开商店的Amazon Go market部分，他们的卡将被扣款，收据预计将在几个小时内收到，如果不是更快的话。</blockquote></p><p> Items that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.</p><p><blockquote>除了在其他Amazon Go地点可以找到的商品外，还可以提货的商品包括经典的星巴克食品，如真空蛋咬、早餐三明治和蛋白质盒。其中包括厨房火鸡和切达三明治，以及布法罗风格的包装。</blockquote></p><p> In addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.</p><p><blockquote>除此之外，货架上还将摆满当地知名的美食，包括源氏寿司、约克街、木兰面包店、Ess-a-bagel等。</blockquote></p><p> As Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.</p><p><blockquote>随着星巴克一头扎进数字化领域，其忠诚度计划使用量飙升，两家公司计划在未来一年内总共开设至少三家星巴克Pickup Amazon Go商店，第二家商店将在位于第40街和第8大道的纽约时报大楼开业。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html\">Yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","SBUX":"星巴克"},"source_url":"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171955198","content_text":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.\nThe team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.\nThe two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.\nDubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.\nIn order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.\nWhen guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.\nItems that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.\nIn addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.\nAs Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.","news_type":1,"symbols_score_info":{"AMZN":0.9,"SBUX":0.9}},"isVote":1,"tweetType":1,"viewCount":2701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873905868,"gmtCreate":1636817095910,"gmtModify":1636817096030,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"[强] ","listText":"[强] ","text":"[强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873905868","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其努力分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873905136,"gmtCreate":1636817047789,"gmtModify":1636817047907,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Noted with thanks","listText":"Noted with thanks","text":"Noted with thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873905136","repostId":"2182018576","repostType":4,"isVote":1,"tweetType":1,"viewCount":2683,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850729969,"gmtCreate":1634629861937,"gmtModify":1634629867914,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"NIO good","listText":"NIO good","text":"NIO good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850729969","repostId":"2176482124","repostType":2,"isVote":1,"tweetType":1,"viewCount":2100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865166241,"gmtCreate":1632961733831,"gmtModify":1632961734080,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Nice Starbucks","listText":"Nice Starbucks","text":"Nice Starbucks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865166241","repostId":"2171438933","repostType":2,"isVote":1,"tweetType":1,"viewCount":4431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863274190,"gmtCreate":1632403959010,"gmtModify":1632732584892,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/863274190","repostId":"2169608546","repostType":2,"isVote":1,"tweetType":1,"viewCount":1935,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869978430,"gmtCreate":1632239090320,"gmtModify":1632801826388,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3587034259149930","idStr":"3587034259149930"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869978430","repostId":"1140143812","repostType":4,"repost":{"id":"1140143812","kind":"news","pubTimestamp":1632233062,"share":"https://www.laohu8.com/m/news/1140143812?lang=zh_CN&edition=full","pubTime":"2021-09-21 22:04","market":"us","language":"en","title":"Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?<blockquote>Greenidge Generation Holdings(GREE)、Support.com(SPRT)股票新闻和预测：格力为何下跌？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1140143812","media":"fxstreet","summary":"GREE shares continue to collapse after the merger deal with Support.com (SPRT).\nGREE stock falls ove","content":"<p><ul> <li><b>GREE shares continue to collapse after the merger deal with Support.com (SPRT).</b></li> <li><b>GREE stock falls over 20% on Monday.</b></li> <li><b>Equity markets suffer, but retail names really fall as volatility is high.</b></li> </ul> GREE shares continue to make a name for themselves for all the wrong reasons as the calamitous fall continues on Monday. Things were already bleak for those long from the old SPRT ticker, but since GREE took over things have gone from bad to worse. GREE fell another 22% on Monday to close just over $30. GREE peaked at $60 last week and so had lost half of its value in just four trading sessions. What investors and traders must be wondering is how much more pain is to come?</p><p><blockquote><ul><li><b>与Support.com(SPRT)合并后，格力股价继续暴跌。</b></li><li><b>格力股价周一下跌超过20%。</b></li><li><b>股市受到影响，但由于波动性很高，散户股票确实下跌。</b></li></ul>随着周一灾难性下跌的继续，格力股价继续因各种错误的原因而出名。对于那些长期持有旧SPRT股票的人来说，情况已经很黯淡，但自从格力接手以来，情况变得越来越糟。格力周一再跌22%，收盘略高于30美元。格力上周达到60美元的峰值，因此在短短四个交易日内就损失了一半的价值。投资者和交易者一定想知道的是，还会有多少痛苦？</blockquote></p><p> GREE stock news</p><p><blockquote>格力股票新闻</blockquote></p><p> Just as a back story, GREE was formed as Greenidge Generation Holdings took over Support.com. Support.com had traded under the ticker SPRT and was a meme stock favourite with a large retail following enthusiastically discussing the stock on social media. SPRT stock had exhibited huge price swings just as with a lot of other retail or meme names. Back in March of this year is when things started to get interesting and when retail traders started to really notice the stock. The deal with Greenidge was announced in March. Support.com was a good fit for retail traders as it was a facilitator of remote working solutions, which grew in popularity during the pandemic. However, Support.com is a much smaller entity despite having a public listing.</p><p><blockquote>作为背景故事，格力是在Greenidge Generation Holdings收购Support.com时成立的。Support.com的股票代码为SPRT，在社交媒体上热烈讨论该股票后，它是大型散户最喜欢的模因股票。与许多其他零售或模因名称一样，SPRT股票也出现了巨大的价格波动。回到今年三月，事情开始变得有趣，散户交易者开始真正注意到这只股票。与Greenidge的交易于三月份宣布。Support.com非常适合零售交易者，因为它是远程工作解决方案的推动者，而远程工作解决方案在大流行期间越来越受欢迎。然而，尽管Support.com公开上市，但其实体规模要小得多。</blockquote></p><p> After the merger, Support.com became a small part or subsidiary of Greenidge. SPRT shares spiked on the announcement of this deal back in March but went quiet again until retail interest appeared to pick up in August. SPRT stock was circulating around various social media chat sites as the short interest was high, meaning the retail traders decided to try and instigate a short squeeze. This has obviously worked well in other meme names such as GME and AMC, but SPRT was not exactly in the same situation. SPRTstockwas to become a much smaller piece of the overall GREE company. There have also been valuation concerns that the SPRT spike had put a much too high valuation on the combined GREE company. Investors sold as a result. Usually in a merger or takeover, positions in the old ticker are rolled into the new one.</p><p><blockquote>合并后，Support.com成为Greenidge的一小部分或子公司。早在3月份宣布这笔交易后，SPRT股价就飙升，但随后又平静下来，直到8月份散户兴趣似乎有所回升。由于空头兴趣很高，SPRT股票在各种社交媒体聊天网站上流通，这意味着散户交易者决定尝试发起轧空。这显然在GME和AMC等其他模因名称中运行良好，但SPRT的情况并不完全相同。SPRT股票在整个格力公司中所占的份额要小得多。还有人担心，SPRT的飙升使合并后的格力公司的估值过高。投资者因此抛售。通常在合并或收购中，旧股票代码中的头寸会转入新股票代码。</blockquote></p><p> GREE stock forecast</p><p><blockquote>格力股票预测</blockquote></p><p> As we can see from the chart below, the point of control since GREE launched is at $47.56 with the Volume Weighted Average Price (VWAP) just below at $43. This is a volume resistance then as most of the volume has been here. There is not much historical data to look through for the chart otherwise, and thevolatilitymakes anyanalysisrather difficult. Please use risk control in all names, but particularily one as volatile as this.</p><p><blockquote>从下图可以看出，格力推出以来的控制点为47.56美元，成交量加权平均价格（VWAP）略低于43美元。这是一个体积阻力，因为大部分体积都在这里。否则，图表就没有太多历史数据可供查看，而且波动性使分析变得相当困难。请在所有名称中使用风险控制，尤其是像这样不稳定的名称。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4002c7efb50cc1afa912ddea168ab7b7\" tg-width=\"2097\" tg-height=\"1200\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Greenidge Generation falls nearly 9% in morning trading.<img src=\"https://static.tigerbbs.com/1cb93fe02339099c8852eaa00d07bd9d\" tg-width=\"1185\" tg-height=\"583\" width=\"100%\" height=\"auto\"></p><p><blockquote>Greenidge Generation早盘下跌近9%。</blockquote></p><p></p>","source":"lsy1617153743470","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?<blockquote>Greenidge Generation Holdings(GREE)、Support.com(SPRT)股票新闻和预测：格力为何下跌？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGreenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?<blockquote>Greenidge Generation Holdings(GREE)、Support.com(SPRT)股票新闻和预测：格力为何下跌？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">fxstreet</strong><span class=\"h-time small\">2021-09-21 22:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul> <li><b>GREE shares continue to collapse after the merger deal with Support.com (SPRT).</b></li> <li><b>GREE stock falls over 20% on Monday.</b></li> <li><b>Equity markets suffer, but retail names really fall as volatility is high.</b></li> </ul> GREE shares continue to make a name for themselves for all the wrong reasons as the calamitous fall continues on Monday. Things were already bleak for those long from the old SPRT ticker, but since GREE took over things have gone from bad to worse. GREE fell another 22% on Monday to close just over $30. GREE peaked at $60 last week and so had lost half of its value in just four trading sessions. What investors and traders must be wondering is how much more pain is to come?</p><p><blockquote><ul><li><b>与Support.com(SPRT)合并后，格力股价继续暴跌。</b></li><li><b>格力股价周一下跌超过20%。</b></li><li><b>股市受到影响，但由于波动性很高，散户股票确实下跌。</b></li></ul>随着周一灾难性下跌的继续，格力股价继续因各种错误的原因而出名。对于那些长期持有旧SPRT股票的人来说，情况已经很黯淡，但自从格力接手以来，情况变得越来越糟。格力周一再跌22%，收盘略高于30美元。格力上周达到60美元的峰值，因此在短短四个交易日内就损失了一半的价值。投资者和交易者一定想知道的是，还会有多少痛苦？</blockquote></p><p> GREE stock news</p><p><blockquote>格力股票新闻</blockquote></p><p> Just as a back story, GREE was formed as Greenidge Generation Holdings took over Support.com. Support.com had traded under the ticker SPRT and was a meme stock favourite with a large retail following enthusiastically discussing the stock on social media. SPRT stock had exhibited huge price swings just as with a lot of other retail or meme names. Back in March of this year is when things started to get interesting and when retail traders started to really notice the stock. The deal with Greenidge was announced in March. Support.com was a good fit for retail traders as it was a facilitator of remote working solutions, which grew in popularity during the pandemic. However, Support.com is a much smaller entity despite having a public listing.</p><p><blockquote>作为背景故事，格力是在Greenidge Generation Holdings收购Support.com时成立的。Support.com的股票代码为SPRT，在社交媒体上热烈讨论该股票后，它是大型散户最喜欢的模因股票。与许多其他零售或模因名称一样，SPRT股票也出现了巨大的价格波动。回到今年三月，事情开始变得有趣，散户交易者开始真正注意到这只股票。与Greenidge的交易于三月份宣布。Support.com非常适合零售交易者，因为它是远程工作解决方案的推动者，而远程工作解决方案在大流行期间越来越受欢迎。然而，尽管Support.com公开上市，但其实体规模要小得多。</blockquote></p><p> After the merger, Support.com became a small part or subsidiary of Greenidge. SPRT shares spiked on the announcement of this deal back in March but went quiet again until retail interest appeared to pick up in August. SPRT stock was circulating around various social media chat sites as the short interest was high, meaning the retail traders decided to try and instigate a short squeeze. This has obviously worked well in other meme names such as GME and AMC, but SPRT was not exactly in the same situation. SPRTstockwas to become a much smaller piece of the overall GREE company. There have also been valuation concerns that the SPRT spike had put a much too high valuation on the combined GREE company. Investors sold as a result. Usually in a merger or takeover, positions in the old ticker are rolled into the new one.</p><p><blockquote>合并后，Support.com成为Greenidge的一小部分或子公司。早在3月份宣布这笔交易后，SPRT股价就飙升，但随后又平静下来，直到8月份散户兴趣似乎有所回升。由于空头兴趣很高，SPRT股票在各种社交媒体聊天网站上流通，这意味着散户交易者决定尝试发起轧空。这显然在GME和AMC等其他模因名称中运行良好，但SPRT的情况并不完全相同。SPRT股票在整个格力公司中所占的份额要小得多。还有人担心，SPRT的飙升使合并后的格力公司的估值过高。投资者因此抛售。通常在合并或收购中，旧股票代码中的头寸会转入新股票代码。</blockquote></p><p> GREE stock forecast</p><p><blockquote>格力股票预测</blockquote></p><p> As we can see from the chart below, the point of control since GREE launched is at $47.56 with the Volume Weighted Average Price (VWAP) just below at $43. This is a volume resistance then as most of the volume has been here. There is not much historical data to look through for the chart otherwise, and thevolatilitymakes anyanalysisrather difficult. Please use risk control in all names, but particularily one as volatile as this.</p><p><blockquote>从下图可以看出，格力推出以来的控制点为47.56美元，成交量加权平均价格（VWAP）略低于43美元。这是一个体积阻力，因为大部分体积都在这里。否则，图表就没有太多历史数据可供查看，而且波动性使分析变得相当困难。请在所有名称中使用风险控制，尤其是像这样不稳定的名称。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/4002c7efb50cc1afa912ddea168ab7b7\" tg-width=\"2097\" tg-height=\"1200\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Greenidge Generation falls nearly 9% in morning trading.<img src=\"https://static.tigerbbs.com/1cb93fe02339099c8852eaa00d07bd9d\" tg-width=\"1185\" tg-height=\"583\" width=\"100%\" height=\"auto\"></p><p><blockquote>Greenidge Generation早盘下跌近9%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fxstreet.com/news/greenidge-generation-holdings-gree-supportcom-sprt-stock-news-and-forecast-why-is-gree-down-202109211205\">fxstreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GREE":"Greenidge Generation Holdings Inc."},"source_url":"https://www.fxstreet.com/news/greenidge-generation-holdings-gree-supportcom-sprt-stock-news-and-forecast-why-is-gree-down-202109211205","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140143812","content_text":"GREE shares continue to collapse after the merger deal with Support.com (SPRT).\nGREE stock falls over 20% on Monday.\nEquity markets suffer, but retail names really fall as volatility is high.\n\nGREE shares continue to make a name for themselves for all the wrong reasons as the calamitous fall continues on Monday. Things were already bleak for those long from the old SPRT ticker, but since GREE took over things have gone from bad to worse. GREE fell another 22% on Monday to close just over $30. GREE peaked at $60 last week and so had lost half of its value in just four trading sessions. What investors and traders must be wondering is how much more pain is to come?\nGREE stock news\nJust as a back story, GREE was formed as Greenidge Generation Holdings took over Support.com. Support.com had traded under the ticker SPRT and was a meme stock favourite with a large retail following enthusiastically discussing the stock on social media. SPRT stock had exhibited huge price swings just as with a lot of other retail or meme names. Back in March of this year is when things started to get interesting and when retail traders started to really notice the stock. The deal with Greenidge was announced in March. Support.com was a good fit for retail traders as it was a facilitator of remote working solutions, which grew in popularity during the pandemic. However, Support.com is a much smaller entity despite having a public listing.\nAfter the merger, Support.com became a small part or subsidiary of Greenidge. SPRT shares spiked on the announcement of this deal back in March but went quiet again until retail interest appeared to pick up in August. SPRT stock was circulating around various social media chat sites as the short interest was high, meaning the retail traders decided to try and instigate a short squeeze. This has obviously worked well in other meme names such as GME and AMC, but SPRT was not exactly in the same situation. SPRTstockwas to become a much smaller piece of the overall GREE company. There have also been valuation concerns that the SPRT spike had put a much too high valuation on the combined GREE company. Investors sold as a result. Usually in a merger or takeover, positions in the old ticker are rolled into the new one.\nGREE stock forecast\nAs we can see from the chart below, the point of control since GREE launched is at $47.56 with the Volume Weighted Average Price (VWAP) just below at $43. This is a volume resistance then as most of the volume has been here. There is not much historical data to look through for the chart otherwise, and thevolatilitymakes anyanalysisrather difficult. Please use risk control in all names, but particularily one as volatile as this.\n\nGreenidge Generation falls nearly 9% in morning trading.","news_type":1,"symbols_score_info":{"GREE":0.9}},"isVote":1,"tweetType":1,"viewCount":1789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}